Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NORDIC BIOTECH OPPORTUNITY FUND K/S
K/S
Active
CVR 31262488
Strandvejen 125, 2900
Hellerup
Other financial service activities, except insurance and pension funding n.e.c.
· NACE 6499
Est. 2008
— employees
Watchlist
Share
Denmark
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
NORDIC BIOTECH OPPORTUNITY FUND K/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
-1M
2020
-5M
2021
-39M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
—
—
—
-107
-93
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-1.128
-5.222
-38.867
-107
-93
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-1.128
-5.222
-38.867
-107
-93
Net financials
-1.028
-5.121
-38.760
1.438
88.540
Profit before tax
-1.138
-5.233
-38.875
1.331
88.447
Tax
-0
-0
-0
-0
-0
Net profit
-1.138
-5.233
-38.875
1.331
88.447
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
65.939
60.705
21.822
23.163
111.609
Equity
65.872
60.639
21.764
23.095
111.542
Long-term debt
0
0
0
0
0
Short-term debt
67
66
58
68
67
Total debt
67
66
58
68
67
Financial ratios
5-year trend
EBITDA margin
-9300000.0%
This company
15.8%
Market median
-58860859% vs market
2020
2024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
79.3%
This company
18.4%
Market median
+331% vs market
2020
2024
Net profit margin
8844700000.0%
This company
8.1%
Market median
+109193827060% vs market
2020
2024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on NORDIC BIOTECH OPPORTUNITY FUND K/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
